DE NICOLA, Luca
 Distribuzione geografica
Continente #
EU - Europa 20.472
NA - Nord America 11.880
AS - Asia 9.390
SA - Sud America 1.468
Continente sconosciuto - Info sul continente non disponibili 464
AF - Africa 126
OC - Oceania 8
Totale 43.808
Nazione #
RU - Federazione Russa 13.410
US - Stati Uniti d'America 11.697
SG - Singapore 3.216
IE - Irlanda 2.179
CN - Cina 2.092
HK - Hong Kong 1.532
BR - Brasile 1.228
UA - Ucraina 1.169
GB - Regno Unito 944
VN - Vietnam 899
IT - Italia 885
DE - Germania 669
IN - India 515
TR - Turchia 333
FI - Finlandia 321
KR - Corea 303
SE - Svezia 299
GR - Grecia 188
BD - Bangladesh 120
JP - Giappone 113
FR - Francia 111
AR - Argentina 96
CA - Canada 79
AT - Austria 58
MX - Messico 54
NL - Olanda 48
BE - Belgio 43
EC - Ecuador 40
IQ - Iraq 36
ES - Italia 34
ZA - Sudafrica 33
PK - Pakistan 31
CZ - Repubblica Ceca 30
ID - Indonesia 28
CO - Colombia 27
MA - Marocco 21
TN - Tunisia 21
VE - Venezuela 20
MY - Malesia 19
PH - Filippine 19
CL - Cile 18
IR - Iran 17
PL - Polonia 16
PY - Paraguay 16
UZ - Uzbekistan 16
JM - Giamaica 13
SA - Arabia Saudita 13
IL - Israele 11
KE - Kenya 11
KZ - Kazakistan 11
LT - Lituania 10
AE - Emirati Arabi Uniti 9
CH - Svizzera 9
UY - Uruguay 9
EG - Egitto 8
EU - Europa 8
PE - Perù 8
TH - Thailandia 8
HU - Ungheria 7
CR - Costa Rica 6
NI - Nicaragua 6
PT - Portogallo 6
TW - Taiwan 6
AL - Albania 5
AU - Australia 5
BO - Bolivia 5
NP - Nepal 5
OM - Oman 5
RS - Serbia 5
SC - Seychelles 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
CI - Costa d'Avorio 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GE - Georgia 4
KG - Kirghizistan 4
LB - Libano 4
DK - Danimarca 3
JO - Giordania 3
LV - Lettonia 3
MK - Macedonia 3
RO - Romania 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
DZ - Algeria 2
GA - Gabon 2
GT - Guatemala 2
HN - Honduras 2
KH - Cambogia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RW - Ruanda 2
SI - Slovenia 2
SV - El Salvador 2
Totale 43.321
Città #
Moscow 4.773
Dublin 2.177
Jacksonville 1.752
Santa Clara 1.563
Hong Kong 1.526
Singapore 1.294
San Jose 1.126
Chandler 1.119
Ashburn 502
Chicago 492
Bengaluru 441
Princeton 343
Hefei 316
Ho Chi Minh City 309
Seoul 289
Medford 279
Wilmington 269
Beijing 250
Dallas 213
Hanoi 213
Roxbury 210
Boardman 209
Ann Arbor 168
San Mateo 157
New York 150
Falls Church 133
The Dalles 126
Woodbridge 119
São Paulo 114
Naples 105
Los Angeles 98
Istanbul 96
Munich 96
Cambridge 85
Des Moines 80
Bremen 75
Nanjing 69
Jinan 62
Caserta 56
Da Nang 54
Milan 49
Rio de Janeiro 46
Brussels 42
Nuremberg 42
Rome 42
Houston 41
Norwalk 41
Haiphong 38
Mountain View 35
Shenyang 35
Belo Horizonte 34
Napoli 33
Zhengzhou 33
Saint Petersburg 32
Guangzhou 30
Orem 30
Vienna 28
Brno 27
Shanghai 27
Frankfurt am Main 25
Tianjin 24
Atlanta 23
Helsinki 23
Tokyo 22
Brooklyn 21
Changsha 21
Council Bluffs 21
Curitiba 21
Biên Hòa 20
Düsseldorf 19
Ercolano 19
Hangzhou 19
Hải Dương 19
Ningbo 19
Chennai 18
Nanchang 18
San Francisco 18
Taizhou 18
Campinas 17
London 17
Quito 17
Turku 17
Bologna 16
Johannesburg 16
Phoenix 15
Sorocaba 15
Taiyuan 15
Toronto 15
Amsterdam 14
Buenos Aires 14
Dhaka 14
Falkenstein 14
Lanzhou 14
Mexico City 14
Montreal 14
Seattle 14
Porto Alegre 13
Thái Bình 13
Auburn Hills 12
Boston 12
Totale 22.903
Nome #
Ethanol and in-vitro Vascular Reactivity of Rats Mesenteric-Artery 835
Sustained Recovery of Kidney Function in Patients with ESKD under Chronic Dialysis Treatment: Systematic Review and Meta-Analysis 366
A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population 235
Empagliflozin in Patients with Chronic Kidney Disease 234
Ruolo del refilling plasmatico dopo dialisi alternativa: valutazione dei dati bioimpedenzometrici 204
Reassessment of Ambulatory Blood Pressure Improves Renal Risk Stratification in Nondialysis Chronic Kidney Disease: Long-Term Cohort Study 191
Amino acid loss during dialysis treatment 180
Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels 177
Alterazioni del bilancio idro-elettrolitico nell’insufficienza renale acuta: implicazioni cliniche 176
L'impiego dell’ Emodiafiltrazione con reinfusione endogena (HFR) nell'infiammazione cronica idiopatica: una possibile alternativa terapeutica? 174
Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology 174
Absence of acute nephrotoxicity with low doses of cyclosporin: experimental study in the rat 173
Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects 173
Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter Prospective Cohort Study 170
[Anti-diabetics and chronic kidney disease] 170
[Iron deficiency in ND-CKD: from diagnosis to treatment] 168
[Hyperuricaemia and Chronic Kidney Disease] 168
Conversion of darbepoetin to low doses of CERA maintains hemoglobin levels in non-dialysis chronic kidney disease patients 165
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy 165
Antiproteinuric Response to Dual Blockade of RAS in Primary Glomerulonephritis: Meta-Analysis and Meta-Regression 165
Assessment of achieved clinic and ambulatory BP recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study. 161
Assesement of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients wih CKD: a multicenter prospective cohort study 161
Independent role of underlying kidney disease on renal prognosis of patients with chronic kidney disease under nephrology care 160
[Clinical experience with ferric carboxymaltose in non-dialysis chronic kidney disease] 159
Daily nutrient intake in hemodialysis. 158
Antiproteinuric response to add-on aliskiren in proteinuric patients treated with dual blockade of the renin-angiotensin system: a 12-month prospective uncontrolled study 157
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy 157
CHRONIC CYCLOSPORINE A NEPHROTOXICITY - A MORPHOLOGICAL AND FUNCTIONAL-STUDY IN RATS 157
[Peritoneal dialysis catheter infection with abscess of the abdominal wall in a ADPKD patient] 157
Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure 156
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension 154
Mesangial hypercellularity predicts antiproteinuric response to dual blockade of RAS in primary glomerulonephritis 153
Achievement of target blood pressure levels in chronic kidney disease: a salty question ? 153
Area Deprivation and Risk of Death and CKD Progression: Long-Term Cohort Study in Patients under Unrestricted Nephrology Care 153
15-year-change of phenotype and prognosis in non-dialysis CKD patients referred to a nephrology clinic 152
Burden of resistant hypertension in hypertensive patients with non-dialysis chronic kidney disease 152
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 152
Alterations of hydro-electrolyte balance in acute renal failure: clinical implications 151
[Epidemiology and prognosis of chronic kidney disease in Italy] 151
Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease 149
Blood pressure variability, mortality, and cardiovascular outcomes in CKD patients 149
Clinical management of the patient affected with acute renal failure (ARF) secondary to volume depletion 148
[Hyperkalemia treatment in chronic kidney disease patients: overview on new cation exchange resins and possible therapeutic approaches] 148
Abnormalities of bioimpedance measures in overweight and obese hemodialyzed patients 146
Acute cyclosporine A nephrotoxicity 145
A new diuretic: the Atrial Natriuretic Peptide 145
Acute renal and immunological effects of low-dose cyclosporin in humans 143
[Census of the renal and dialysis units by Italian Society of Nephrology: structure and organization for renal patient assistance in Italy (2014-2015)] 143
Chronic Hyperkaliemia in Chronic Kidney Disease: An Old Concern with New Answers 142
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 142
Prevalence and Prognostic Role of Resistant Hypertension in Chronic Kidney Disease Patients 141
Disfunzione renale nell’anziano: processo fisiologico o malattia? 141
Management of hypertension in patients with CKD: differences between primary and tertiary care settings 140
Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008-12 National Health Examination Survey 139
Ruolo dell’ossido nitrico nella regolazione dell’emodinamica glomerulare 138
Antiproteinuric effect of paricalcitol in kidney transplant recipients with severe proteinuria: a prospective cohort study 137
Epidemiology of chronic kidney disease in Italy: the CARHES study 137
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 137
Epidemiology of CKD Regression in Patients under Nephrology Care 137
Sodium removal by peritoneal dialysis: a systematic review and meta-analysis 136
Management of hypertension in chronic kidney disease: the Italian multicenter study. 135
Acute effects of low-dose cyclosporine on renal function in normal subjects 135
Comprehensive audit of antihypertensive treatment in patients with chronic renal insufficiency (CRI): The Italian Multicentre survey 135
Renal Disease 135
Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease 134
Acute effects of cyclosporine on glomerular dynamics--micropuncture study in the rat 134
Ferric carboxymatose in non-hemodialysis ckd patients: A longitudinal cohort study 134
Anemia: A Connection Between Heart Failure and Kidney Failure 134
Role of paracalcitol in the management of non-dialysis CKD: state of art and unmeet needs. 132
Prevalence and Prognosis of Mild Anemia in Non-Dialysis CKD: A Prospective Cohort Study in Outpatient Renal Clinics 132
AMBULATORY BLOOD PRESSURE (ABP) AND RESISTANT HYPERTENSION (RH): TWO INCREMENTAL PREDICTORS OF LONG TERM COMPLICATIONS IN NON-DIALYSIS CKD 132
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. 132
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 131
Sex difference in cardiovascular risk in patients with chronic kidney disease: pooled analysis of four cohort studies 131
Effect of hemodiafiltration with endogenous reinfusion on overt idiopathic chronic inflammation in maintenance hemodialysis patients: A multicenter longitudinal study. 131
Role of inhibition of atrial natriuretic factor release in the down-regulation of salt excretion 131
Epidemiology of chronic kidney disease in Italy: current state and contribution of the CARHES study. 131
Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis 130
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease 130
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 130
Management of hypertension in chronic kidney disease 129
Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy 129
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics 129
Sodium intake and chronic kidney disease 129
Heart Failure in chronic kidney disease: from epidemiology to therapy. 128
Volume-Independent Sodium Toxicity in Peritoneal Dialysis: New Insights from Bench to Bed 127
Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study 127
Prevalence and clinical correlates of white coat hypertension in chronic kidney disease 127
Epidemiology of chronic kidney disease in Italy 127
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure 126
Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. 126
Rebound post-dialitico della fosforemia: implicazioni patogenetiche e cliniche 126
Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. 126
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy 126
Are all erythropoiesis-stimulating agents created equal? 126
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 125
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 125
Very low-protein diet plus ketoacids in chronic kidney disease and risk of death during end-stage renal disease: an historical, cohort, controlled study. 125
Epidemiology of chronic kidney disease in Italy: current situation and contribution of the CARHES study 125
Efficacy of erythropoietin on dialysis in patients with Beta-Thalassemia Minor 125
Totale 15.582
Categoria #
all - tutte 153.644
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 153.644


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.103 0 42 43 82 726 19 44 56 83 145 213 650
2022/20234.441 422 137 318 363 398 342 10 253 1.992 37 75 94
2023/20241.699 150 49 74 172 613 96 38 30 34 32 125 286
2024/20255.897 16 84 81 184 940 893 821 499 637 998 410 334
2025/202622.817 887 1.204 1.168 1.078 1.769 12.565 1.170 983 881 563 326 223
2026/2027481 451 30 0 0 0 0 0 0 0 0 0 0
Totale 43.808